Innoviva Stock Performance
| INVA Stock | USD 22.70 0.26 1.16% |
Innoviva has a performance score of 3 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.39, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Innoviva's returns are expected to increase less than the market. However, during the bear market, the loss of holding Innoviva is expected to be smaller as well. Innoviva right now retains a risk of 1.37%. Please check out Innoviva sortino ratio, skewness, period momentum indicator, as well as the relationship between the potential upside and rate of daily change , to decide if Innoviva will be following its current trending patterns.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Innoviva are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Innoviva is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return 1.16 | Five Day Return 3.75 | Year To Date Return 14.24 | Ten Year Return 79.59 | All Time Return 67.37 |
Last Split Factor 1241:1000 | Dividend Date 2015-09-30 | Ex Dividend Date 2015-09-08 | Last Split Date 2014-06-03 |
1 | Innoviva, Inc. INVA Shares Bought by Marshall Wace LLP - MarketBeat | 12/08/2025 |
2 | Innoviva joins elite list of stocks with 95-plus composite rating - MSN | 01/06/2026 |
3 | Understanding Momentum Shifts in - Stock Traders Daily | 01/12/2026 |
4 | Innoviva Shares Cross Above Two Hundred Day Moving Average - Heres What Happened - MarketBeat | 01/15/2026 |
5 | QRG Capital Management Inc. Has 1.47 Million Position in Innoviva, Inc. INVA | 01/21/2026 |
6 | Assessing Innoviva Valuation After Recent Share Price Cooling | 01/27/2026 |
7 | Universal Beteiligungs und Servicegesellschaft mbH Increases Stock Position in Innoviva, Inc. INVA - MarketBeat | 01/30/2026 |
8 | Acquisition by Denner Alexander J of 50000 shares of Innoviva at 13.0738 subject to Rule 16b-3 | 02/05/2026 |
9 | Innoviva, Inc. Receives Average Rating of Moderate Buy from Analysts | 02/09/2026 |
10 | Innoviva stock hits 52-week high at 22.81 - Investing.com | 02/12/2026 |
| Begin Period Cash Flow | 193.5 M | |
| Total Cashflows From Investing Activities | -63.8 M |
Innoviva Relative Risk vs. Return Landscape
If you would invest 2,197 in Innoviva on November 16, 2025 and sell it today you would earn a total of 73.00 from holding Innoviva or generate 3.32% return on investment over 90 days. Innoviva is currently generating 0.0627% in daily expected returns and assumes 1.3655% risk (volatility on return distribution) over the 90 days horizon. In different words, 12% of stocks are less volatile than Innoviva, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Innoviva Target Price Odds to finish over Current Price
The tendency of Innoviva Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 22.70 | 90 days | 22.70 | about 1.6 |
Based on a normal probability distribution, the odds of Innoviva to move above the current price in 90 days from now is about 1.6 (This Innoviva probability density function shows the probability of Innoviva Stock to fall within a particular range of prices over 90 days) .
Innoviva Price Density |
| Price |
Predictive Modules for Innoviva
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Innoviva. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Innoviva's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Innoviva Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Innoviva is not an exception. The market had few large corrections towards the Innoviva's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Innoviva, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Innoviva within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.10 | |
β | Beta against Dow Jones | 0.39 | |
σ | Overall volatility | 0.97 | |
Ir | Information ratio | 0.05 |
Innoviva Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Innoviva for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Innoviva can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Innoviva stock hits 52-week high at 22.81 - Investing.com |
Innoviva Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Innoviva Stock often depends not only on the future outlook of the current and potential Innoviva's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Innoviva's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 74.2 M | |
| Cash And Short Term Investments | 412.5 M |
Innoviva Fundamentals Growth
Innoviva Stock prices reflect investors' perceptions of the future prospects and financial health of Innoviva, and Innoviva fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Innoviva Stock performance.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0816 | ||||
| Profit Margin | 0.33 % | ||||
| Operating Margin | 0.32 % | ||||
| Current Valuation | 1.4 B | ||||
| Shares Outstanding | 74.77 M | ||||
| Price To Earning | 5.67 X | ||||
| Price To Book | 1.66 X | ||||
| Price To Sales | 4.37 X | ||||
| Revenue | 358.71 M | ||||
| Gross Profit | 328.35 M | ||||
| EBITDA | 85.5 M | ||||
| Net Income | 23.39 M | ||||
| Cash And Equivalents | 283.58 M | ||||
| Cash Per Share | 4.07 X | ||||
| Total Debt | 451.1 M | ||||
| Debt To Equity | 0.96 % | ||||
| Current Ratio | 3.18 X | ||||
| Book Value Per Share | 13.51 X | ||||
| Cash Flow From Operations | 188.69 M | ||||
| Earnings Per Share | 1.66 X | ||||
| Market Capitalization | 1.66 B | ||||
| Total Asset | 1.3 B | ||||
| Retained Earnings | (1.8 M) | ||||
| Working Capital | 318.22 M | ||||
| Current Asset | 214.32 M | ||||
| Current Liabilities | 13.49 M | ||||
About Innoviva Performance
By analyzing Innoviva's fundamental ratios, stakeholders can gain valuable insights into Innoviva's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Innoviva has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Innoviva has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 302.71 | 317.85 | |
| Return On Tangible Assets | 0.02 | 0.02 | |
| Return On Capital Employed | 0.14 | 0.15 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.03 | 0.03 |
Things to note about Innoviva performance evaluation
Checking the ongoing alerts about Innoviva for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Innoviva help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Innoviva stock hits 52-week high at 22.81 - Investing.com |
- Analyzing Innoviva's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Innoviva's stock is overvalued or undervalued compared to its peers.
- Examining Innoviva's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Innoviva's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Innoviva's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Innoviva's stock. These opinions can provide insight into Innoviva's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Innoviva Stock analysis
When running Innoviva's price analysis, check to measure Innoviva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innoviva is operating at the current time. Most of Innoviva's value examination focuses on studying past and present price action to predict the probability of Innoviva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innoviva's price. Additionally, you may evaluate how the addition of Innoviva to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |